《Journal Of Pharmacology And Experimental Therapeutics》雜志影響因子：3.1。
期刊Journal Of Pharmacology And Experimental Therapeutics近年評價數(shù)據(jù)趨勢圖
期刊影響因子趨勢圖
以下是一些常見的影響因子查詢?nèi)肟冢?
（1）Web of Science：是查詢SCI期刊影響因子的權(quán)威平臺，收錄全球高質(zhì)量學(xué)術(shù)期刊，提供詳細(xì)的期刊引證報告，包括影響因子、分區(qū)、被引頻次等關(guān)鍵指標(biāo)。
（2）?Journal Citation Reports (JCR)：JCR是科睿唯安旗下的一個網(wǎng)站，提供了期刊影響因子、引用數(shù)據(jù)和相關(guān)指標(biāo)。用戶可以在該網(wǎng)站上查找特定期刊的影響因子信息。
（3）中科院SCI期刊分區(qū)表：提供中科院分區(qū)的期刊數(shù)據(jù)查詢，包括影響因子和分區(qū)信息。
《Journal Of Pharmacology And Experimental Therapeutics》雜志是由American Society for Pharmacology and Experimental Therapeutics出版社主辦的一本以醫(yī)學(xué)-藥學(xué)為研究方向，OA非開放（Not Open Access）的國際優(yōu)秀期刊。
該雜志出版語言為English，創(chuàng)刊于1909年。自創(chuàng)刊以來，已被SCIE（科學(xué)引文索引擴展板）等國內(nèi)外知名檢索系統(tǒng)收錄。該雜志發(fā)表了高質(zhì)量的論文，重點介紹了PHARMACOLOGY & PHARMACY在分析和實踐中的理論、研究和應(yīng)用。
?學(xué)術(shù)地位：在JCR分區(qū)中位列Q2區(qū)，中科院分區(qū)為醫(yī)學(xué)大類3區(qū)，PHARMACOLOGY & PHARMACY藥學(xué)小類3區(qū)。
期刊發(fā)文分析
機構(gòu)發(fā)文量統(tǒng)計
| 機構(gòu) | 發(fā)文量 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 20 |
| UNIVERSITY OF TEXAS SYSTEM | 19 |
| STATE UNIVERSITY OF NEW YORK (SUNY) SYSTEM | 16 |
| VIRGINIA COMMONWEALTH UNIVERSITY | 14 |
| US DEPARTMENT OF VETERANS AFFAIRS | 13 |
| PENNSYLVANIA COMMONWEALTH SYSTEM OF HIGHER... | 12 |
| STATE UNIVERSITY SYSTEM OF FLORIDA | 12 |
| UNIVERSITY OF MINNESOTA SYSTEM | 12 |
| UNIVERSITY OF NORTH CAROLINA | 12 |
| UNIVERSITY OF WASHINGTON | 12 |
國家 / 地區(qū)發(fā)文量統(tǒng)計
| 國家 / 地區(qū) | 發(fā)文量 |
| USA | 396 |
| CHINA MAINLAND | 74 |
| Japan | 63 |
| England | 36 |
| Canada | 29 |
| GERMANY (FED REP GER) | 26 |
| Italy | 26 |
| Spain | 22 |
| Australia | 19 |
| France | 18 |
期刊引用數(shù)據(jù)次數(shù)統(tǒng)計
| 期刊引用數(shù)據(jù) | 引用次數(shù) |
| J PHARMACOL EXP THER | 421 |
| J BIOL CHEM | 310 |
| P NATL ACAD SCI USA | 233 |
| PLOS ONE | 213 |
| J CONTROL RELEASE | 160 |
| BRIT J PHARMACOL | 150 |
| EUR J PHARMACOL | 148 |
| DRUG METAB DISPOS | 146 |
| NATURE | 145 |
| J NEUROSCI | 124 |
期刊被引用數(shù)據(jù)次數(shù)統(tǒng)計
| 期刊被引用數(shù)據(jù) | 引用次數(shù) |
| INT J MOL SCI | 557 |
| SCI REP-UK | 487 |
| J PHARMACOL EXP THER | 421 |
| FRONT PHARMACOL | 415 |
| NEUROPHARMACOLOGY | 397 |
| EUR J PHARMACOL | 300 |
| J MED CHEM | 273 |
| PSYCHOPHARMACOLOGY | 261 |
| ADV EXP MED BIOL | 239 |
| MOLECULES | 238 |
文章引用數(shù)據(jù)次數(shù)統(tǒng)計
| 文章引用數(shù)據(jù) | 引用次數(shù) |
| Ocular Drug Delivery: Present Innovations ... | 29 |
| Ferroptosis as a Novel Therapeutic Target ... | 23 |
| Hydroxychloroquine: A Physiologically-Base... | 20 |
| Binding Characteristics and Analgesic Effe... | 18 |
| Anti-inflammatory Properties of Cannabidio... | 18 |
| Clinically Advanced p38 Inhibitors Suppres... | 18 |
| Quantitative Contribution of Six Major Tra... | 15 |
| Sex Differences in the Pharmacokinetics of... | 15 |
| Pharmacological Evaluation of Dotinurad, a... | 14 |
| Organic Anion Transporter 2-Mediated Hepat... | 14 |
